To further confirm whether the overexpression of FGF9 inhibits NAFLD development induced by HFD, we generated liver-specific FGF9 transgenic mice (FGF9alb-cre) by crossing Alb-Cre mice and FGF9 Rosa26 knockin mice. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.